The new federal classification of marijuana regulates only medical use; recreational use is still determined by state laws.

(BINGHAMTON, NY) When the U.S. Department of Justice moved to reclassify medical marijuana to a Schedule III drug on April 23, 2026, it set the stage for a vast amount of medical research that has been hobbled for decades by its more restrictive Schedule I classification.

The Justice Department also called for an expedited federal rescheduling process, with proceedings expected to begin in late June 2026, but for now cannabis at the federal level remains a Schedule I drug.

Originally published on theconversation.com, part of the BLOX Digital Content Exchange.